|Articles|April 16, 2007

Fixed-combination products offer option for greater IOP-lowering

Fixed-combination therapies may have a role in glaucoma management when monotherapy reduces IOP but not sufficiently to reach the target level, said Luca Rossetti, MD, professor of ophthalmology, University of Milan, Italy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME